SG Americas Securities’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$702K Buy
6,729
+3,978
+145% +$415K ﹤0.01% 1286
2025
Q1
$321K Sell
2,751
-801
-23% -$93.5K ﹤0.01% 1920
2024
Q4
$301K Sell
3,552
-8,001
-69% -$678K ﹤0.01% 1573
2024
Q3
$1.04M Buy
+11,553
New +$1.04M ﹤0.01% 917
2024
Q2
Sell
-15,104
Closed -$1.21M 2434
2024
Q1
$1.21M Buy
15,104
+12,963
+605% +$1.03M 0.01% 979
2023
Q4
$170K Buy
+2,141
New +$170K ﹤0.01% 2104
2023
Q2
Sell
-13,269
Closed -$818K 1992
2023
Q1
$818K Buy
13,269
+11,561
+677% +$713K 0.01% 1181
2022
Q4
$132K Sell
1,708
-12,154
-88% -$939K ﹤0.01% 2287
2022
Q3
$619K Buy
13,862
+5,412
+64% +$242K 0.01% 1180
2022
Q2
$324K Sell
8,450
-23,760
-74% -$911K ﹤0.01% 2123
2022
Q1
$1.33M Sell
32,210
-1,033
-3% -$42.8K 0.01% 1077
2021
Q4
$1.26M Sell
33,243
-49,823
-60% -$1.88M 0.01% 1342
2021
Q3
$2.74M Buy
83,066
+39,559
+91% +$1.3M 0.01% 900
2021
Q2
$2.94M Sell
43,507
-10,843
-20% -$731K 0.01% 813
2021
Q1
$3.08M Buy
54,350
+2,119
+4% +$120K 0.02% 678
2020
Q4
$4.26M Buy
52,231
+32,423
+164% +$2.64M 0.02% 510
2020
Q3
$1.41M Buy
19,808
+5,319
+37% +$379K 0.01% 808
2020
Q2
$1.19M Buy
14,489
+2,559
+21% +$211K 0.01% 1037
2020
Q1
$702K Buy
11,930
+6,864
+135% +$404K 0.01% 1239
2019
Q4
$524K Buy
+5,066
New +$524K ﹤0.01% 1497
2019
Q3
Sell
-6,478
Closed -$167K 2456
2019
Q2
$167K Buy
+6,478
New +$167K ﹤0.01% 2171
2017
Q2
Sell
-35,734
Closed -$139K 2660
2017
Q1
$139K Buy
+35,734
New +$139K ﹤0.01% 2411